Use of sodium glucose cotransporter 2 (SGLT2) inhibitors to treat type 2 diabetes may help to lower the risk of serious kidney problems, finds a study published by The BMJ today.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/04/200429191849.htm
No comments:
Post a Comment